Hipnosedon

Hipnosedon is a prescription benzodiazepine medication marketed by Farmasyn in Greece for the short-term treatment of severe insomnia. Its active ingredient is flunitrazepam, a potent small molecule that acts as a positive allosteric modulator of the GABA-A receptor. By binding to the benzodiazepine receptors (BNZ1 and BNZ2) coupled to the GABA-A complex, it enhances the inhibitory effects of the neurotransmitter gamma-aminobutyric acid (GABA), leading to sedative, hypnotic, anxiolytic, and muscle-relaxant effects. It is typically administered orally as a 1mg tablet and is classified as a controlled substance due to its high potency and potential for misuse. Although sometimes categorized broadly as a sleep product, it is a pharmaceutical drug rather than a nutraceutical or over-the-counter supplement.

Brand names

Hipnosedon

Other names

flunitrazepam